Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma

Clinical trial NCT04973098 · UNKNOWN

Trial details

NCT number: NCT04973098
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2021-08-05
Primary completion: 2022-08-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.